Assessment of hepatic vascular network connectivity with automated graph analysis of dynamic contrast-enhanced us to evaluate portal hypertension in patients with cirrhosis: A pilot study1

Radiology

Volumn 277, Issue 1, 2015, Pages 268-276

  Amat Roldan, Ivan ^a   Berzigotti, Annalisa ^b   Gilabert, Rosa ^c   Bosch, Jaime ^b  

^a Expert Ymaging SL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SONOVUE; CONTRAST MEDIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEMODYNAMIC PARAMETERS; HEPATIC VENOUS PRESSURE GRADIENT MEASUREMENT; HUMAN; LIVER BLOOD FLOW; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PILOT STUDY; PORTAL HYPERTENSION; PRESSURE GRADIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME SERIES ANALYSIS; VENOUS PRESSURE; AGED; COMPLICATION; LIVER; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VASCULARIZATION;

ADULT; AGED; CONTRAST MEDIA; FEMALE; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY;

EID: 84942413741     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015141941     Document Type: Article

References (19)

1. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995;21(5): 1238-1247.
2. Bosch J. Vascular deterioration in cirrhosis: the big picture. J Clin Gastroenterol 2007; 41(Suppl 3):S247-S253.
3. Lim A, Cosgrove D. Functional studies. Eur Radiol 2004;14(Suppl 8):P110-P115.
4. Federlein J, Postert T, Meves S, Weber S, Przuntek H, Büttner T. Ultrasonic evaluation of pathological brain perfusion in acute stroke using second harmonic imaging. J Neurol Neurosurg Psychiatry 2000;69(5):616-622.
5. Lepper W, Hoffmann R, Kamp O, et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction. Circulation 2000;101(20):2368-2374.
6. Wei K, Le E, Bin JP, Coggins M, Thorpe J, Kaul S. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol 2001;37(4):1135-1140.
7. Berzigotti A, Nicolau C, Bellot P, et al. Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis. J Hepatol 2011;55(2):307-314.
8. Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 2009;10(3):186-198.
9. Blinder P, Shih AY, Rafie C, Kleinfeld D. Topological basis for the robust distribution of blood to rodent neocortex. Proc Natl Acad Sci U S A 2010;107(28):12670-12675.
10. Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6(10):573-582.
11. Morel DR, Schwieger I, Hohn L, et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 2000;35(1):80-85.
12. Watts DJ, Strogatz SH. Collective dynamics of 'small-world' networks. Nature 1998;393 (6684):440-442.
13. Onnela JP, Saramäki J, Kertész J, Kaski K. Intensity and coherence of motifs in weighted complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 2005;71(6 Pt 2):065103.
14. Burroughs AK, Groszmann R, Bosch J, et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? Gut 2002;50(3):425-427.
15. Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 2012;56(3): 696-703.
16. Bosch J, Abraldes JG, Fernández M, García-Pagán JC. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol 2010;53(3):558-567.
17. Hudson JM, Williams R, Lloyd B, et al. Improved flow measurement using microbubble contrast agents and disruption-replenishment: clinical application to tumour monitoring. Ultrasound Med Biol 2011;37(8): 1210-1221.
18. Hudson JM, Leung K, Burns PN. The lognormal perfusion model for disruption replenishment measurements of blood flow: in vivo validation. Ultrasound Med Biol 2011;37(10):1571-1578.
19. Hudson JM, Williams R, Karshafian R, et al. Quantifying vascular heterogeneity using microbubble disruption-replenishment kinetics in patients with renal cell cancer. Invest Radiol 2014;49(2):116-123.